City of Hope is at the
2025 ASTRO Annual Meeting
Our world-class radiation oncologists and thought leaders will present new findings from their leading-edge research programs and offer expert perspectives on Sept. 27 to Oct. 1, 2025, at the 2025 American Society for Radiation Oncology (ASTRO) annual meeting in San Francisco, CA.
Our cancer centers in Southern California, Arizona, Illinois and Georgia offer comprehensive radiation services and are recognized by the ASTRO's APEx Accreditation Program for Excellence.
Please visit us in the exhibition hall at Booth No. 3303 to learn more about our treatment and research breakthroughs, renowned experts and employment opportunities.
R.S.V.P. Now for an Evening with City of Hope
Ritz-Carlton Ballroom
Marriott Marquis San Francisco | The View
780 Mission Street, San Francisco, CA 94103
Official meeting badge must be worn for admittance.
R.S.V.P. by Sept. 21, 2025.
Hosted by:
Terence M. Williams, M.D., Ph.D., is professor and chair of the Department of Radiation Oncology, City of Hope in Duarte, Southern California.
Meet and Greet with our Renowned Experts
Sunday, Sept. 28 | 1 to 2 p.m. PT
Learn more about City of Hope’s Radiation Oncology Residency Program.
Scott Glaser, M.D., is a radiation oncologist and an assistant professor of radiation oncology at City of Hope.
Colton Ladbury, M.D., is a radiation oncologist and assistant clinical professor in the Department of Radiation Oncology at City of Hope.
Monday, Sept. 29 | 10:30 to 11:30 a.m. PT
Learn more about City of Hope’s national system.
Kristin Higgins, MD, joined City of Hope® Cancer Center Atlanta in January 2024 as Chief Clinical Officer, leading the hospital’s efforts supporting advanced cancer care access and innovation, while also partnering with department chairs to lead physician recruitment and clinical growth.
Percy Lee, M.D., is delighted to increase City of Hope's reach and help establish its radiation oncology research network in his role as medical director of Orange County and coastal region radiation oncology and vice chair for clinical research in the Department of Radiation Oncology.
Tuesday, Sept. 30 | 1 to 2 p.m. PT
Learn about City of Hope’s Radiation Oncology Residency Program.
Arya Amini, M.D., is a radiation oncologist and associate professor in the Department of Radiation Oncology at City of Hope.
Highlighted Abstract Presentations
Scientific Sessions
132 — Consolidative Radiotherapy with Osimertinib in Advanced EGFR-Mutant Non-Small Cell Lung Cancer: Long-Term Local and Intracranial Control Results from a Phase II Trial
Sunday, Sept. 28, 3:20-3:30 p.m. PT
130 — High-Dimensional Immunophenotyping of Patients with Localized Non-Small Cell Lung Cancer (NSCLC) Reveals Distinct Immune Cell Subsets Predictive of Disease-Free Survival (DFS) in AFT-16 and LCMC3 Phase II Immunotherapy Clinical Trials
Sunday, Sept. 28, 3-3:10 p.m. PT
E2F1-Fanconi Anemia Complementation Group I (FANCI) Mediates Oncogenic BRAF-Driven Radiation Resistance in Anaplastic Thyroid Cancer
Sunday, Sept. 28, 2:50-3 p.m. PT
202 — CNS Bridging Radiotherapy prior to CAR T Cell Therapy for B-Cell Lymphomas
Monday, Sept. 29, 11:15-11:25 a.m. PT
Education Sessions
Radiotherapy for Leukemia: Past, Present and Future
Sunday, Sept. 28, 4:45-6 p.m. PT
The Future of Radiation Therapy for Leukemia
Sunday, Sept. 28, 5:32-5:47 p.m. PT
Riding the Waves of New Small Cell Lung Cancer Therapeutics
Tuesday, Sept. 30, 12:45-2 p.m.
Immunotherapy in Limited Stage Small Cell Lung Cancer — Dissecting the Data
Tuesday, Sept. 30, 2025, 12:45-2 p.m.
Awards
Nicholas Eustace, M.D., Ph.D.
Recipient of the Annual Meeting Basic Translational Award
Ari Kassardjian, M.D.
Winner of the 2025 ASTRO-AstraZeneca SCLC Therapy Challenge
Resources
City of Hope's Department of Radiation Oncology has long been at the forefront of providing the best evidence-based clinical care, forging technological advances and translating discoveries from the bench into clinical practice.
In the global pursuit of scientific miracles in the fight against deadly diseases, the Beckman Research Institute of City of Hope is among those leading the charge. Its world-renowned staff have been responsible for fundamentally expanding the world’s understanding of how biology affects diseases such as cancer, HIV/AIDS and diabetes.
City of Hope has joined forces with the TGen to accelerate the speed with which scientists and medical staff convert research discoveries into cures for patients. The alliance is based on a simple premise: City of Hope provides a state-of-the-art clinical setting in which to advance genomic breakthroughs made by TGen.
We’re aggressively pursuing ways to help our patients right now — not years from now. That immediacy of focus makes City of Hope a worldwide leader in administering clinical trials. Each year, we conduct more than 730 clinical trials, enrolling more than 5,000 patients.
We are a leader in clinical and translational research, most notably in antibody-based therapy, CAR T cell therapy and bone marrow transplant approaches. When you refer your patient to City of Hope, you can do so with the utmost confidence that our staff will provide the best care possible for your patient.
City of Hope is ever-expanding — whether it’s at our main campus in Duarte, California, the Orange County campus or one of our 30+ clinical network locations. In order to provide premier care throughout Southern California, we seek physicians with a passion for high-quality patient care.
